Increased insulin clearance in peroxisome proliferator-activated receptor γ2 Pro12Ala

被引:26
|
作者
Tschritter, O [1 ]
Fritsche, A [1 ]
Stefan, N [1 ]
Haap, M [1 ]
Thamer, C [1 ]
Bachmann, O [1 ]
Dahl, D [1 ]
Maerker, E [1 ]
Teigeler, A [1 ]
Machicao, F [1 ]
Häring, H [1 ]
Stumvoll, M [1 ]
机构
[1] Univ Tubingen, Med Klin, Abt Endokrinol Stoffwechsel & Pathochem, D-72076 Tubingen, Germany
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2003年 / 52卷 / 06期
关键词
D O I
10.1016/S0026-0495(03)00071-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPARgamma2) is associated with reduced risk for type 2 diabetes. Although increased insulin sensitivity of glucose disposal and lipolysis has been reported, the exact mechanism by which the risk reduction is conferred is not clear. Because the conclusion of greater insulin sensitivity hinged upon lower insulin levels in some studies, it is possible that more efficient insulin clearance is involved. We therefore estimated insulin clearance during a euglycemic hyperinsulinemic clamp (insulin infusion rate divided by steady-state insulin concentration, 229 normal glucose tolerant [NGT] subjects), an oral glucose tolerance test (OGTT) (mean C-peptide divided by mean insulin concentrations, 406 NGT, 54 impaired glucose tolerant or mildly diabetic subjects), and a hyperglycemic clamp (120 minutes, 10 mmol/L, C-peptide divided by insulin in the steady-state, 56 NGT subjects). In the carriers of the Ala allele (prevalence similar to24%), insulin clearance in all 3 protocols was significantly greater (similar to 10%), than in controls. While the results from the euglycemic clamp reflect both hepatic and peripheral insulin clearance; those from the OGTT and the hyperglycemic clamp reflect mainly hepatic insulin extraction. Free fatty acids (FFA) during the steady state of the euglycemic hyperinsulinemic clamp were significantly lower in carriers of the Ala allele (26 +/- 5 mumol/L) than in controls (46 +/- 3 mumol/L, P = .02). In conclusion, the Pro12Ala polymorphism is associated with increased insulin clearance. This could be the result of reduced FFA delivery, which has been shown to improve hepatic insulin removal and sensitivity. Because PPARgamma2 is mainly expressed in adipose tissue, one of the main regulatory effects of the polymorphism may well be the more efficient suppression of (possibly intra-abdominal) lipolysis. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:778 / 783
页数:6
相关论文
共 50 条
  • [31] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ/PRO12ALA POLYMORPHISM AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ COACTIVATOR-1 ALPHA/GLY482SER POLYMORPHISM IN PATIENTS WITH SARCOIDOSIS
    Maver, A.
    Medica, I.
    Salobir, B.
    Tercelj-Zorman, M.
    Sabovic, M.
    Petrovic, D.
    Peterlin, B.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2008, 25 (01) : 29 - 35
  • [32] Association of Peroxisome Proliferator-Activated Receptor-Gamma 2 Pro12Ala Polymorphism with Advanced-Stage Endometriosis
    Hwang, Kyu Ri
    Choi, Young Min
    Kim, Jong Mee
    Lee, Gyoung Hoon
    Kim, Jin Ju
    Chae, Soo Jin
    Moon, Shin Yong
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2010, 64 (05) : 333 - 338
  • [33] Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations
    Beamer, BA
    Yen, CJ
    Andersen, BE
    Muller, D
    Elahi, D
    Cheskin, LJ
    Andres, R
    Roth, J
    Shuldiner, AR
    DIABETES, 1998, 47 (11) : 1806 - 1808
  • [34] Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men
    Mori, Y
    Kim-Motoyama, H
    Katakura, T
    Yasuda, K
    Kadowaki, H
    Beamer, BA
    Shuldiner, AR
    Akanuma, Y
    Yazaki, Y
    Kadowaki, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 251 (01) : 195 - 198
  • [35] Association of Pro12Ala variant in peroxisome proliferator - Activated receptor with type 2 diabetes mellitus
    Mao, F
    Bin, W
    Hua, C
    DIABETOLOGIA, 2001, 44 : A90 - A90
  • [36] The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene on glucose/insulin metabolism interact with prenatal exposure to famine
    De Rooij, SR
    Painter, RC
    Phillips, DIW
    Osmond, C
    Tanck, MWT
    Defesche, JC
    Bossuyt, PMM
    Michels, RPJ
    Bleker, OP
    Roseboom, TJ
    DIABETES CARE, 2006, 29 (05) : 1052 - 1057
  • [37] Influence of Pro12Ala peroxisome proliferator-activated receptor γ2 polymorphism on glucose response to exercise training in type 2 diabetes
    K. B. Adamo
    R. J. Sigal
    K. Williams
    G. Kenny
    D. Prud’homme
    F. Tesson
    Diabetologia, 2005, 48 : 1503 - 1509
  • [38] Influence of Pro12Ala peroxisome proliferator-activated receptor γ2 polymorphism on glucose response to exercise training in type 2 diabetes
    Adamo, KB
    Sigal, RJ
    Williams, K
    Kenny, G
    Prud'homme, D
    Tesson, F
    DIABETOLOGIA, 2005, 48 (08) : 1503 - 1509
  • [39] Pro12Ala mutation in the peroxisome proliferator-activated receptor γ2 (PPARγ2) and severe obesity:: a case-control study
    Vaccaro, O
    Mancini, FP
    Ruffa, G
    Sabatino, L
    Colantuoni, V
    Riccardi, G
    INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (09) : 1195 - 1199
  • [40] Association between the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene and Strength Athlete Status
    Maciejewska-Karlowska, Agnieszka
    Sawczuk, Marek
    Cieszczyk, Pawel
    Zarebska, Aleksandra
    Sawczyn, Stanislaw
    PLOS ONE, 2013, 8 (06):